Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Allakos Inc
(NQ:
ALLK
)
1.010
+0.116 (+12.95%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Allakos Inc
< Previous
1
2
3
4
Next >
10 Health Care Stocks Whale Activity In Today's Session
November 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 22, 2024
Via
Benzinga
ALLK Stock Earnings: Allakos Beats EPS for Q2 2024
August 07, 2024
ALLK stock results show that Allakos beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
ALLK Stock Earnings: Allakos Meets EPS for Q1 2024
May 09, 2024
ALLK stock results show that Allakos met analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
ALLK Stock Earnings: Allakos Misses EPS for Q4 2023
March 14, 2024
ALLK stock results show that Allakos missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
October 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 04, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 03, 2024
Pre-market stock movers are worth checking out this morning as we dive into all of the biggest news moving shares on Friday!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 01, 2024
Via
Benzinga
Where Allakos Stands With Analysts
December 18, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About Allakos
November 28, 2023
Via
Benzinga
Why Shares of Allakos Are Up Wednesday
September 27, 2023
The stock is bouncing back from a recent 52-week low.
Via
The Motley Fool
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 15, 2024
We are starting the trading week with a dive into the biggest pre-market stock movers worth keeping tabs on for Monday morning!
Via
InvestorPlace
3 Biotech Stocks to Dump Before They Go to Zero
April 09, 2024
These biotech stocks to sell are burning through cash at an alarming rate and seem destined for zero, making them prime targets for selling.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 14, 2024
Via
Benzinga
Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday
January 17, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 17, 2024
Via
Benzinga
Gold Down 1%; PNC Financial Posts Upbeat Earnings
January 16, 2024
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 350 points on Tuesday. The Dow traded down 0.93% to 37,243.85 while the NASDAQ fell 0.58% to 14,885.45. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 16, 2024
Via
Benzinga
Crude Oil Edges Lower; Morgan Stanley Posts Upbeat Revenue
January 16, 2024
U.S. stocks traded mostly lower midway through trading, with the Dow Jones index falling more than 150 points on Tuesday. The Dow traded down 0.46% to 37,421.80 while the NASDAQ fell 0.02% to...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Is Allakos (ALLK) Stock Down 57% Today?
January 16, 2024
Allakos stock is falling hard on Tuesday as investors in ALLK react to two of the company's Phase 2 clinical trials failing.
Via
InvestorPlace
Trial Setback: Allakos Drops Lead Skin Disorder Candidate, Cuts Workforce By 50%
January 16, 2024
Allakos reports disappointing topline data from phase 2 trials for lirentelimab in atopic dermatitis and chronic spontaneous urticaria. Company undergoes restructuring to focus on AK006, extending cash...
Via
Benzinga
Dow Dips 200 Points; Goldman Sachs Earnings Top Views
January 16, 2024
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.56% to 37,384.20 while the NASDAQ...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 16, 2024
Via
Benzinga
Allakos Analyst Turns Bullish, Sees 'Significant Upside' If Study Results Are Positive
December 18, 2023
Shares of Allakos Inc (NASDAQ: ALLK) were climbing in early trading on Monday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
November 09, 2023
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping tabs on for Thursday morning!
Via
InvestorPlace
Allakos' Antibodies For Chronic Skin Conditions, Analyst Sees Over 400% Stock Upside
September 27, 2023
JMP Securities initiated coverage on Allakos Inc (NASDAQ: ALLK), noting novel monoclonal antibodies targeting Siglec (sialic acid immunoglobulin-like lectin) receptors on immune cells that are drivers...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
September 27, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.